Unfortunately, the Trump administration and the Republican majorities in Congress are putting access to lifesaving ...

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

Innovation, inclusion, and urgency  define Kigali HIV conference ANALYSIS | RONALD MUSOKE | When the 13th International AIDS ...

South Africa has the world’s largest HIV treatment programme, with over 5. 5 million people receiving antiretrovirals (ARVs).

Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...

PEPFAR was launched in 2003 to stop the spread of HIV in Africa. Now, although some funding remains for the program, many of ...

A landmark breakthrough in HIV prevention — a scientific feat decades in the making — received final approval from the Food ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...

As expected, the new recommendations that the World Health Organization (WHO) issued for HIV and sexually transmitted ...

Despite the recent approval of lenacapavir as a twice yearly PrEP, there is still a need for choice in HIV prevention, argue ...

Lenacapavir, a long-acting injectable pre-exposure prophylaxis, has been recommended by the WHO to help protect high-risk ...